Effects of a Supportive Mobile Health for Life Style Modification on Blood Pressure and Insulin Resistance Improvement in People With Metabolic Abnormalities
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Metabolic Syndrome
- Sponsor
- Yonsei University
- Enrollment
- 129
- Locations
- 1
- Primary Endpoint
- Change in systolic/diastolic blood pressures
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The purpose of this randomized study is to assess the efficacy of a mobile application for the improvement of blood pressure and insulin resistance in people with metabolic abnormalities.
Detailed Description
The purpose of this randomized study is to assess the efficacy of a mobile application for the improvement of blood pressure and insulin resistance in people with metabolic syndrome. This study is a 24 week follow up randomized prevention trial. Participants visit for a screening test, then eligible participants are randomly assigned for one of the following arms; 1 intervention group using a mobile application to monitor their life style behaviors, 1 intervention group using a mobile application for personal coaching on purpose of improving their life style behavior, and 1 control group providing education about managing life style behaviors.
Investigators
Eligibility Criteria
Inclusion Criteria
- •"Etiologic study on cardiovascular and metabolic diseases: prospective cohort study (Severance Hospital IRB No. 4-2013-0661)" participants
- •Smartphone user
- •Metabolic abnormality. Having 2 or more components of metabolic syndrome described below:
- •Central obesity : waist circumference ≥ 90cm in male, ≥ 80cm in female
- •Systolic/diastolic blood pressure ≥ 130/85 mmHg
- •Serum triglyceride ≥ 150 mg/dL
- •Serum high density lipoprotein cholesterol \< 40 mg/dL in male, 50 mg/dL in female
- •Fasting glucose ≥ 100mg/dL
Exclusion Criteria
- •Presently or planning for pregnant/breastfeeding during the study. Or confirmed pregnancy by a urine test.
- •Currently taking medication (including insulin injection) for hypertension, dyslipidemia, or diabetes.
- •Presently using a mobile application for lifestyle modification
Outcomes
Primary Outcomes
Change in systolic/diastolic blood pressures
Time Frame: 24 weeks
Change of systolic/diastolic blood pressures and insulin resistance are the differences between the last visit and baseline (screening visit).
Secondary Outcomes
- Change in the eligibility criteria for metabolic syndrome(24 weeks)